JP Morgan Chase’s CureVac CVAC Stock Holding History

JP Morgan Chase’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-290,000	Closed	-$879K	–	7407
2024 Q1	$879K	Hold	290,000	–	–	﹤0.01%	4442
2023 Q4	$1.22M	Buy	290,000 +168,200	+138%	+$912K	﹤0.01%	4197
2023 Q3	$832K	Buy	+121,800	New	+$1.08M	﹤0.01%	4180
2021 Q1	–	Sell	-40,000	Closed	-$3.24M	–	6104
2020 Q4	$3.24M	Buy	+40,000	New	+$3.06M	﹤0.01%	3141

JP Morgan Chase's CVAC Position: Q1 2026 in Review

JP Morgan Chase sold out of CureVac (CVAC) in Q1 2026, closing a stake of 123 shares — an estimated $556 sold.

JP Morgan Chase first reported a position in CVAC in Q4 2020 and held it in 16 quarters. The position peaked at $4.08M in Q1 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

JP Morgan Chase reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
JP Morgan Chase sold 123 CureVac shares in Q1 2026, an estimated $556.
JP Morgan Chase first reported a position in CureVac in Q4 2020 and held it in 16 quarters.
JP Morgan Chase's CureVac position peaked at $4.08M in Q1 2021.
0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.